AeroLeads people directory · profile
Kevin Chow Email & Phone Number
Co-founder, President and CEO
at
Mitera Biosciences
1 work email found
@vitaerisbio.com
2 phones found area 604 and 844
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Co-founder, President and CEO
Location
Greater Seattle Area, United States, United States
Who is Kevin Chow? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Kevin Chow is listed as Co-founder, President and CEO at Mitera Biosciences, based in Greater Seattle Area, United States, United States. AeroLeads shows a work email signal at vitaerisbio.com, phone signal with area code 604, 844, and a matched LinkedIn profile for Kevin Chow.
Kevin Chow previously worked as Co-founder, President & CEO at Mitera Biosciences and President & Chief Operating Officer at Incisive Genetics. Kevin Chow holds Ph.D., Microbiology And Immunology from The University Of British Columbia.
Company email context
Email format at Mitera Biosciences
This section adds company-level context without repeating Kevin Chow's masked contact details.
{first}.{last}@vitaerisbio.com
86% confidence
AeroLeads found 1 current-domain work email signal for Kevin Chow. Compare company email patterns before reaching out.
Profile bio
About Kevin Chow
Kevin Chow has over two decades of experience leading business development, corporate strategy and operations in the biopharmaceutical industry. Dr. Chow is the co-founder, President & CEO of Mitera Biosciences, an autoimmune disease focused bioventure established in collaboration with Cedars Sinai (Los Angeles). He also serves as President of Incisive Genetics, focusing on non-viral delivery of CRISPR gene editing using lipid nanoparticles. Previously he was co-founder, President and CEO of Vitaeris (acquired by CSL Behring in June 2020), a biotechnology company conducting a multi-national Phase 3 study in kidney transplant rejection. Prior to co-founding Vitaeris in early 2016, Dr. Chow served as Head of Business Development at Alder Biopharmaceuticals, where he led partnering efforts for Alder’s monoclonal antibody pipeline. Previously, Dr. Chow led pulmonary in-licensing at Gilead Sciences and served as Director of Business Development for Corus Pharma, a specialty pharmaceutical company focused on cystic fibrosis and asthma drug development. From 2000-2003 Dr. Chow served in various business development roles with Diversa Corporation.Dr. Chow holds B.Sc., M.Sc., and Ph.D. degrees in Microbiology and Immunology from the University of British Columbia in Vancouver, Canada.
Listed skills include Biotechnology, Biopharmaceuticals, Technology Transfer, Drug Development, and 21 others.
Current workplace
Kevin Chow's current company
Company context helps verify the profile and gives searchers a useful next step.
Mitera Biosciences
Website
AeroLeads page
9 roles
Kevin Chow work experience
A career timeline built from the work history available for this profile.
Co-Founder, President & Ceo
CurrentReimagining the future of immunotherapy for transplantation and autoimmune diseases. Leveraging proprietary technologies exclusively licensed from Cedars Sinai Medical Center in Los Angeles, at Mitera we are focused on the development of a novel injectable approach for in vivo regulatory T cell modulation.
Jan 2024 - Present
President & Chief Operating Officer
CurrentIncisive Genetics is focused on developing an innovative lipid nanoparticle (LNP) delivery platform for genetic therapies. We believe our proprietary platform provides a solution to the most critical challenge to effective CRISPR-based gene therapy — the effective and safe in vivo delivery of active RNP gene editing machinery into target tissues. Our.
Mar 2021 - Present
Co-Founder, President & Chief Executive Officer
Co-founder, chief executive, and board member of Vitaeris, a clinical stage biopharmaceutical company focused on development of the anti-IL-6 monoclonal antibody clazakizumab for treatment of chronic rejection in kidney transplant. Led negotiations with CSL Behring on strategic collaboration and purchase option deal, announced in December 2017. Vitaeris.
Jan 2016 - Aug 2020
Senior Director And Head Of Business Development
Alder Biopharmaceuticals Inc. (Nasdaq: Aldr)
Head of business development for Alder. Member of deal team for Alder's Phase 2 licensing and collaboration partnership around ALD518 (clazakizumab) with Bristol-Myers Squibb, announced in November 2009. Assisted in preparations for successful initial public offering on NASDAQ in May 2014. Championed and led successful formation of new venture-funded.
May 2009 - Jun 2016
Associate Director, Corporate Development
Led in-licensing of CF/COPD pulmonary drug development program from Parion Sciences. Licensed enabling assay technology for internal anti-viral research efforts leading to discovery and development of RSV fusion inhibitor GS-5806. Performed primary and secondary market research in support of licensing efforts. Participated in strategic planning process at.
Aug 2006 - May 2009
Director, Business Development
Led in-licensing search and evaluation activities. Played key role in integration of Corus into Gilead Sciences after acquisition in 2006. Cayston(R) (aztreonam for inhalation solution) was approved by the the U.S. FDA in February 2010 for use by cystic fibrosis patients.
Oct 2005 - Aug 2006
Sr. Manager, Business Development
Sep 2003 - Oct 2005
Manager, Pharma Business Development
Managed monoclonal antibody therapeutics partnering activities. Member of deal team for anti-infective asset acquisition from GlaxoSmithKline in 2003.
Jul 2000 - Aug 2003
3 education records
Kevin Chow education
Ph.D., Microbiology And Immunology
The University Of British Columbia
M.Sc., Microbiology And Immunology
The University Of British Columbia
B.Sc., Microbiology And Immunology
The University Of British Columbia
FAQ
Frequently asked questions about Kevin Chow
Quick answers generated from the profile data available on this page.
What company does Kevin Chow work for?
Kevin Chow works for Mitera Biosciences.
What is Kevin Chow's role at Mitera Biosciences?
Kevin Chow is listed as Co-founder, President and CEO at Mitera Biosciences.
What is Kevin Chow's email address?
AeroLeads has found 1 work email signal at @vitaerisbio.com for Kevin Chow at Mitera Biosciences.
What is Kevin Chow's phone number?
AeroLeads has found 2 phone signal(s) with area code 604, 844 for Kevin Chow at Mitera Biosciences.
Where is Kevin Chow based?
Kevin Chow is based in Greater Seattle Area, United States, United States while working with Mitera Biosciences.
What companies has Kevin Chow worked for?
Kevin Chow has worked for Mitera Biosciences, Incisive Genetics, Vitaeris Inc., Alder Biopharmaceuticals Inc. (Nasdaq: Aldr), and Gilead Sciences.
How can I contact Kevin Chow?
You can use AeroLeads to view verified contact signals for Kevin Chow at Mitera Biosciences, including work email, phone, and LinkedIn data when available.
What schools did Kevin Chow attend?
Kevin Chow holds Ph.D., Microbiology And Immunology from The University Of British Columbia.
What skills is Kevin Chow known for?
Kevin Chow is listed with skills including Biotechnology, Biopharmaceuticals, Technology Transfer, Drug Development, Oncology, Lifesciences, Pharmaceutical Industry, and Molecular Biology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial